Key facts
- It has raised $50.0M; the latest was Later Stage VC ($50.0M) in Jul 2025.
- Notable investors include Mirae Asset Global Investments (Hong Kong).
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Puliyan Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Puliyan Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Puliyan Medical
Manufacturer of medical polymer materials and biological tissue engineering products aims to advance wound care and medical aesthetics. The company's offerings feature liquid dressings, hyaluronic acid dressings, recombinant collagen, medical cold compresses, repair tablets, repair freeze-dried powder, surgical masks, and sutures, helping hospitals, clinics, and skincare professionals enhance healing efficiency, improve skin repair, and support innovative treatment solutions, enabling broader adoption of high-quality medical and cosmetic care products.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2018
- Website
- puliyan.com/
- Ownership
- Privately Held (backing)
Puliyan Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Puliyan Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Puliyan Medical in its N-PORT filings yet. We sweep new filings monthly.